FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2978199957> ?p ?o ?g. }

• W2978199957 endingPage "S768" @default.
• W2978199957 startingPage "S768" @default.
• W2978199957 abstract "Introduction: We assessed the effect of adalimumab dose escalation on risk of hospitalization in patients with moderately to severely active UC who did not respond or lost response after adalimumab induction therapy. Methods: Data were pooled from two randomized, double-blind, placebo-controlled phase 3 trials of adalimumab in patients with moderately to severely active UC (ULTRA 1 and 2: NCT00385736; NCT00408629). Patients randomized to adalimumab 160/80 mg induction therapy at weeks 0/2 followed by adalimumab 40 mg EOW who later dose escalated to 40 mg every week owing to non-response or loss of response were included in the analysis. Kaplan-Meier time-to-event analysis was used to estimate observed risks of all-cause and UC-related hospitalization within 90 days after dose escalation. Cox proportional hazards models were used to establish the relationship between hospitalization (both all-cause and UC-related) and partial Mayo scores after dose escalation, controlling for age, sex, prior anti-tumor necrosis factor (anti-TNF) status (naive or experienced), and partial Mayo score before dose escalation. This model's coefficients were then used to predict the 90-day all-cause and UC-related hospitalization risks had no dose escalation occurred, by assuming no changes in patients' partial Mayo scores in the period after dose escalation vs before dose escalation. Results: Of 122 patients who escalated to weekly adalimumab dosing, the majority were male (68%) and naive to anti-TNF agents (74%); mean age was 39.5 years and mean UC duration was 8.3 years. Mean partial Mayo score decreased from 6.8 before dose escalation to an average of 5.17 after dose escalation. For patients who dose escalated, the observed (Kaplan Meier) 90-day all-cause and UC-related hospitalization risks were 8.7% and 6.7%, respectively. The predicted 90-day all-cause and UC-related hospitalization risks, had patients continued on EOW therapy, were 13.0% and 10.3%, respectively. The relative risk of both all-cause and UC-related hospitalization in patients who dose escalated was lowered by 33.2% and 35.5%, respectively, compared with the predicted risk without dose escalation, reflecting the benefits of dose adjustment. Conclusion: Dose escalation of adalimumab in patients with moderately to severely active UC who did not respond or lost response after induction therapy reduced the 90-day risk of hospitalization and reflected a benefit of adalimumab dose escalation for treating these UC patients." @default.
• W2978199957 created "2019-10-10" @default.
• W2978199957 creator A5011681788 @default.
• W2978199957 creator A5018825142 @default.
• W2978199957 creator A5032150391 @default.
• W2978199957 creator A5048464948 @default.
• W2978199957 creator A5050304186 @default.
• W2978199957 creator A5056966450 @default.
• W2978199957 creator A5079001382 @default.
• W2978199957 creator A5079729596 @default.
• W2978199957 date "2015-10-01" @default.
• W2978199957 modified "2023-09-23" @default.
• W2978199957 title "Effect of Adalimumab Dose Escalation on Hospitalization Risk in Patients With Moderately to Severely Active Ulcerative Colitis" @default.
• W2978199957 doi "https://doi.org/10.14309/00000434-201510001-01808" @default.
• W2978199957 hasPublicationYear "2015" @default.
• W2978199957 type Work @default.
• W2978199957 sameAs 2978199957 @default.
• W2978199957 citedByCount "0" @default.
• W2978199957 crossrefType "journal-article" @default.
• W2978199957 hasAuthorship W2978199957A5011681788 @default.
• W2978199957 hasAuthorship W2978199957A5018825142 @default.
• W2978199957 hasAuthorship W2978199957A5032150391 @default.
• W2978199957 hasAuthorship W2978199957A5048464948 @default.
• W2978199957 hasAuthorship W2978199957A5050304186 @default.
• W2978199957 hasAuthorship W2978199957A5056966450 @default.
• W2978199957 hasAuthorship W2978199957A5079001382 @default.
• W2978199957 hasAuthorship W2978199957A5079729596 @default.
• W2978199957 hasConcept C126322002 @default.
• W2978199957 hasConcept C142724271 @default.
• W2978199957 hasConcept C17991360 @default.
• W2978199957 hasConcept C204787440 @default.
• W2978199957 hasConcept C27081682 @default.
• W2978199957 hasConcept C2777288759 @default.
• W2978199957 hasConcept C2779134260 @default.
• W2978199957 hasConcept C2780132546 @default.
• W2978199957 hasConcept C2780479503 @default.
• W2978199957 hasConcept C50382708 @default.
• W2978199957 hasConcept C71924100 @default.
• W2978199957 hasConceptScore W2978199957C126322002 @default.
• W2978199957 hasConceptScore W2978199957C142724271 @default.
• W2978199957 hasConceptScore W2978199957C17991360 @default.
• W2978199957 hasConceptScore W2978199957C204787440 @default.
• W2978199957 hasConceptScore W2978199957C27081682 @default.
• W2978199957 hasConceptScore W2978199957C2777288759 @default.
• W2978199957 hasConceptScore W2978199957C2779134260 @default.
• W2978199957 hasConceptScore W2978199957C2780132546 @default.
• W2978199957 hasConceptScore W2978199957C2780479503 @default.
• W2978199957 hasConceptScore W2978199957C50382708 @default.
• W2978199957 hasConceptScore W2978199957C71924100 @default.
• W2978199957 hasLocation W29781999571 @default.
• W2978199957 hasOpenAccess W2978199957 @default.
• W2978199957 hasPrimaryLocation W29781999571 @default.
• W2978199957 hasRelatedWork W1946705845 @default.
• W2978199957 hasRelatedWork W2020640954 @default.
• W2978199957 hasRelatedWork W2020873782 @default.
• W2978199957 hasRelatedWork W2064903759 @default.
• W2978199957 hasRelatedWork W2594662902 @default.
• W2978199957 hasRelatedWork W3147486766 @default.
• W2978199957 hasRelatedWork W4309263759 @default.
• W2978199957 hasRelatedWork W4316077561 @default.
• W2978199957 hasRelatedWork W4378515922 @default.
• W2978199957 hasRelatedWork W1540884887 @default.
• W2978199957 hasVolume "110" @default.
• W2978199957 isParatext "false" @default.
• W2978199957 isRetracted "false" @default.
• W2978199957 magId "2978199957" @default.
• W2978199957 workType "article" @default.